Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials

Linda Stein Gold, April W Armstrong, Jennifer Soung, Ronald B Vender, Álvaro González Cantero, Matthias Hoffmann, Scott T Guenthner, H Chih-Ho Hong, Dedee F Murrell, Eingun James Song, Leon Kircik, Matthias Augustin, Maxwell Sauder, Sascha Gerdes, Ofelia Reyes-Servin, Bassey Effiom Edem, Jennifer Campbell, Kellen Cresswell, Lea Kephart, Shu Li, Ya-Wen Yang, Robert Bissonnette

Open source

DOI: 10.1093/bjd/ljag264
Published: 2026-07-03
Container: British Journal of Dermatology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/bjd/ljag264,
  title = {Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials},
  author = {Linda Stein Gold and April W Armstrong and Jennifer Soung and Ronald B Vender and Álvaro González Cantero and Matthias Hoffmann and Scott T Guenthner and H Chih-Ho Hong and Dedee F Murrell and Eingun James Song and Leon Kircik and Matthias Augustin and Maxwell Sauder and Sascha Gerdes and Ofelia Reyes-Servin and Bassey Effiom Edem and Jennifer Campbell and Kellen Cresswell and Lea Kephart and Shu Li and Ya-Wen Yang and Robert Bissonnette},
  year = {2026},
  journal = {British Journal of Dermatology},
  doi = {10.1093/bjd/ljag264},
  url = {https://doi.org/10.1093/bjd/ljag264}
}

RIS

TY  - JOUR
TI  - Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials
AU  - Linda Stein Gold
AU  - April W Armstrong
AU  - Jennifer Soung
AU  - Ronald B Vender
AU  - Álvaro González Cantero
AU  - Matthias Hoffmann
AU  - Scott T Guenthner
AU  - H Chih-Ho Hong
AU  - Dedee F Murrell
AU  - Eingun James Song
AU  - Leon Kircik
AU  - Matthias Augustin
AU  - Maxwell Sauder
AU  - Sascha Gerdes
AU  - Ofelia Reyes-Servin
AU  - Bassey Effiom Edem
AU  - Jennifer Campbell
AU  - Kellen Cresswell
AU  - Lea Kephart
AU  - Shu Li
AU  - Ya-Wen Yang
AU  - Robert Bissonnette
PY  - 2026
JO  - British Journal of Dermatology
DO  - 10.1093/bjd/ljag264
UR  - https://doi.org/10.1093/bjd/ljag264
ER  -

APA

Gold, L. S., Armstrong, A. W., Soung, J., Vender, R. B., Cantero, Á. G., Hoffmann, M., Guenthner, S. T., Hong, H. C., Murrell, D. F., Song, E. J., Kircik, L., Augustin, M., Sauder, M., Gerdes, S., Reyes-Servin, O., Edem, B. E., Campbell, J., Cresswell, K., Kephart, L., Li, S., Yang, Y., & Bissonnette, R. (2026). Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag264

Source records

crossref · retrieved 2026-09-24T23:10:33.096Z